Pharma in Brief team

Pharma in Brief team

ID: 1b839947-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

Amended CUSMA no longer extends data protection for biologics

Pharma in Brief · December 11, 2019

Federal Court dismisses motion for determination of an issue of law under the new PM(NOC) Regulations

Pharma in Brief · November 29, 2019

Federal Court refuses to allow fifth generic to join common trial on validity

Pharma in Brief · November 25, 2019

Federal Court of Appeal applies holistic approach to the “palpable and overriding error” standard of review

Pharma in Brief · November 11, 2019

Federal Court refuses to permit reply evidence on validity issues in action under the PM(NOC) Regulations

Pharma in Brief · November 7, 2019

Practice Areas

Health Care and Life Sciences

Jurisdictions